<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?DTDIdentifier.IdentifierValue http://null/schema/dtds/document/fulltext/xcr/xocs-article.xsd?><?DTDIdentifier.IdentifierType schema?><?SourceDTD.DTDName xocs-article.xsd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName ftrr2jats.xsl?><?ConverterInfo.Version 1?><?origin publisher?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Microbiol Immunol Infect</journal-id><journal-id journal-id-type="iso-abbrev">J Microbiol Immunol Infect</journal-id><journal-title-group><journal-title>Journal of Microbiology, Immunology, and Infection</journal-title></journal-title-group><issn pub-type="ppub">1684-1182</issn><issn pub-type="epub">1995-9133</issn><publisher><publisher-name>Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7105047</article-id><article-id pub-id-type="publisher-id">S1684-1182(19)30148-3</article-id><article-id pub-id-type="doi">10.1016/j.jmii.2019.08.013</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Viral etiologies of acute respiratory tract infections among hospitalized children &#x02013; A comparison between single and multiple viral infections</article-title></title-group><contrib-group><contrib contrib-type="author" id="au1"><name><surname>Yen</surname><given-names>Chun-Yu</given-names></name><xref rid="aff1" ref-type="aff">a</xref><xref rid="aff2" ref-type="aff">b</xref></contrib><contrib contrib-type="author" id="au2"><name><surname>Wu</surname><given-names>Wan-Tai</given-names></name><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author" id="au3"><name><surname>Chang</surname><given-names>Chia-Yuan</given-names></name><xref rid="aff1" ref-type="aff">a</xref><xref rid="aff2" ref-type="aff">b</xref></contrib><contrib contrib-type="author" id="au4"><name><surname>Wong</surname><given-names>Ying-Chi</given-names></name><xref rid="aff1" ref-type="aff">a</xref><xref rid="aff2" ref-type="aff">b</xref></contrib><contrib contrib-type="author" id="au5"><name><surname>Lai</surname><given-names>Chou-Cheng</given-names></name><xref rid="aff1" ref-type="aff">a</xref><xref rid="aff2" ref-type="aff">b</xref></contrib><contrib contrib-type="author" id="au6"><name><surname>Chan</surname><given-names>Yu-Jiun</given-names></name><xref rid="aff3" ref-type="aff">c</xref></contrib><contrib contrib-type="author" id="au7"><name><surname>Wu</surname><given-names>Keh-Gong</given-names></name><xref rid="aff1" ref-type="aff">a</xref><xref rid="aff2" ref-type="aff">b</xref></contrib><contrib contrib-type="author" id="au8"><name><surname>Hung</surname><given-names>Miao-Chiu</given-names></name><email>mchung@vghtpe.gov.tw</email><xref rid="aff1" ref-type="aff">a</xref><xref rid="aff2" ref-type="aff">b</xref><xref rid="cor1" ref-type="corresp">&#x02217;</xref></contrib><aff id="aff1"><label>a</label>Department of Pediatrics, Taipei Veterans General Hospital, National Yang-Ming University, Taipei, Taiwan, ROC</aff><aff id="aff2"><label>b</label>Division of Pediatric Infectious Diseases, Department of Pediatrics, Taipei Veterans General Hospital, Taipei, Taiwan, ROC</aff><aff id="aff3"><label>c</label>Division of Microbiology, Department of Pathology and Laboratory Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, ROC</aff></contrib-group><author-notes><corresp id="cor1"><label>&#x02217;</label>Corresponding author. Division of Pediatric Infectious Diseases, Department of Pediatrics, Taipei Veterans General Hospital, No. 201, Section 2, Shih-Pai Road, Taipei 11217, Taiwan, ROC. Fax: +886 2 28739019. <email>mchung@vghtpe.gov.tw</email></corresp></author-notes><pub-date pub-type="pmc-release"><day>30</day><month>9</month><year>2019</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.--><pub-date pub-type="ppub"><month>12</month><year>2019</year></pub-date><pub-date pub-type="epub"><day>30</day><month>9</month><year>2019</year></pub-date><volume>52</volume><issue>6</issue><fpage>902</fpage><lpage>910</lpage><history><date date-type="received"><day>30</day><month>4</month><year>2019</year></date><date date-type="rev-recd"><day>26</day><month>8</month><year>2019</year></date><date date-type="accepted"><day>28</day><month>8</month><year>2019</year></date></history><permissions><copyright-statement>&#x000a9; 2019 Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.</copyright-statement><copyright-year>2019</copyright-year><copyright-holder/><license><license-p>Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.</license-p></license></permissions><abstract id="abs0010"><sec><title>Background</title><p>Acute respiratory tract infections are commonly caused by viruses in children. The differences in clinical data and outcome between single and multiple viral infections in hospitalized children were analyzed.</p></sec><sec><title>Methods</title><p>We retrospectively reviewed the medical records of hospitalized children who had fever and a xTAG Respiratory Virus Panel (RVP) test over a 2-year period. The clinical data were analyzed and compared between single and multiple viral infections. Viral etiologies in upper and lower respiratory infections were analyzed and compared.</p></sec><sec><title>Results</title><p>A total of 442 patients were enrolled. Patients with positive viral detection (N&#x000a0;=&#x000a0;311) had a significantly lower rate of leukocytosis (p&#x000a0;=&#x000a0;0.03), less evidence of bacterial infection (p&#x000a0;=&#x000a0;0.004), and shorter duration of hospitalization (p&#x000a0;=&#x000a0;0.019) than those with negative viral detection. The age of patients with multiple viral infections was younger than those with single viral infection; however, there were no significant differences in duration of fever, antibiotics treatment and hospitalization between these two groups.</p><p>The most commonly identified virus was human rhinovirus. About 27% (n&#x000a0;=&#x000a0;83) of patients had multiple viral infections. Overall, the highest percentage of human bocavirus infection was detected in multiple viral infections (79%). Lower respiratory tract infection (LRTI) was independently associated with multiple viral infections (p&#x000a0;=&#x000a0;0.022), respiratory syncytial virus (RSV) infection (p&#x000a0;=&#x000a0;0.001) and longer hospitalization duration (p&#x000a0;=&#x000a0;0.011).</p></sec><sec><title>Conclusion</title><p>Multiple viral infections were associated with younger age and a higher risk of developing LRTI. However, multiple viral infections did not predict a worse disease outcome. More studies are needed to unveil the interplay between the hosts and different viruses in multiple viral infections.</p></sec></abstract><kwd-group id="kwrds0010"><title>Keywords</title><kwd>Respiratory tract infection</kwd><kwd>Respiratory viral panel</kwd><kwd>Children</kwd><kwd>Single viral infection</kwd><kwd>Multiple viral infections</kwd></kwd-group></article-meta></front><body><sec id="nomen0010"><title>Abbreviations</title><def-list><def-item><term id="d0010">RVP</term><def><p id="p0010">respiratory virus panel</p></def></def-item><def-item><term id="d0015">LRTI</term><def><p id="p0015">lower respiratory tract infection</p></def></def-item><def-item><term id="d0020">RSV</term><def><p id="p0020">respiratory syncytial virus</p></def></def-item><def-item><term id="d0025">ARTI</term><def><p id="p0025">acute respiratory tract infections</p></def></def-item><def-item><term id="d0030">URTI</term><def><p id="p0030">upper respiratory tract infection</p></def></def-item><def-item><term id="d0035">hMPV</term><def><p id="p0035">human metapneumovirus</p></def></def-item><def-item><term id="d0040">HCoV</term><def><p id="p0040">human coronavirus</p></def></def-item><def-item><term id="d0045">HBoV</term><def><p id="p0045">human bocavirus</p></def></def-item><def-item><term id="d0050">ICU</term><def><p id="p0050">intensive care unit</p></def></def-item><def-item><term id="d0055">HAdV</term><def><p id="p0055">human adenovirus</p></def></def-item><def-item><term id="d0060">AOM</term><def><p id="p0060">acute otitis media</p></def></def-item><def-item><term id="d0065">Flu A</term><def><p id="p0065">influenza A virus</p></def></def-item><def-item><term id="d0070">Flu B</term><def><p id="p0070">influenza B virus</p></def></def-item><def-item><term id="d0075">PIV</term><def><p id="p0075">human parainfluenza virus</p></def></def-item><def-item><term id="d0080">EV</term><def><p id="p0080">enterovirus</p></def></def-item><def-item><term id="d0085">HRV</term><def><p id="p0085">human rhinoviruses</p></def></def-item><def-item><term id="d0090">CI</term><def><p id="p0090">confidence interval</p></def></def-item><def-item><term id="d0095">CRP</term><def><p id="p0095">C-reactive protein</p></def></def-item></def-list></sec><sec id="sec1"><title>Introduction</title><p id="p0100">Acute respiratory tract infection (ARTI) is a leading cause of fever and hospitalization in children worldwide.<xref rid="bib1" ref-type="bibr"><sup>1</sup></xref> Upper respiratory tract infection (URTI) is the most frequent human illness and the most common disease in childhood; on average, infants and preschoolers develop six to eight URTIs per year.<xref rid="bib2" ref-type="bibr"><sup>2</sup></xref> URTIs can cause non-severe but widespread epidemics that are responsible for the continuous circulation of pathogens in the community. Moreover, lower respiratory tract infection (LRTI) may also develop severe disease and is the leading infectious cause of death in children younger than five years of age.<xref rid="bib3" ref-type="bibr"><sup>3</sup></xref> For both URTI and LRTI, viral infection is the primary cause, especially in children. Clinically, the febrile presentation could lead to the use of more diagnostic tools and antibiotics. Therefore, accurate and timely identification of the responsible viral pathogen could reduce unnecessary use of antibiotics and length of hospital stay.<xref rid="bib4" ref-type="bibr"><sup>4</sup></xref>
</p><p id="p0105">Multiple viral infections are more commonly seen in pediatric patients than in adults.<xref rid="bib5" ref-type="bibr"><sup>5</sup></xref> Multiple viral infections were reported to be associated with increased hospital admissions, intensive care unit admissions, lengthened duration of hospitalization, and prolonged mechanical ventilation use.<xref rid="bib6" ref-type="bibr">6</xref>, <xref rid="bib7" ref-type="bibr">7</xref>, <xref rid="bib8" ref-type="bibr">8</xref> However, some studies indicated that disease severity, management, and outcome were not associated with multiple viral infections.<xref rid="bib9" ref-type="bibr">9</xref>, <xref rid="bib10" ref-type="bibr">10</xref>, <xref rid="bib11" ref-type="bibr">11</xref>, <xref rid="bib12" ref-type="bibr">12</xref> Interestingly, a study published by Martin et&#x000a0;al. revealed that illnesses with multiple virus detections were correlated with disease of less severity.<xref rid="bib13" ref-type="bibr"><sup>13</sup></xref> Hence, whether multiple viral infections correlate with disease severity remains unclear.</p><p id="p0110">In comparison to traditional viral culture and polymerase chain reaction detection for each viral pathogen, the Luminex xTAG Respiratory Virus Panel (RVP) assay offers simultaneous testing for several common respiratory viruses with improved diagnostic sensitivity along with comparable sensitivity to individual real-time nucleic acid tests.<xref rid="bib14" ref-type="bibr"><sup>14</sup></xref> The sensitivity and specificity of RVP were reported to be 95.2% and 99.6%, respectively.<xref rid="bib15" ref-type="bibr"><sup>15</sup></xref> Furthermore, RVP can detect the presence of new viral pathogens which are not routinely cultivated or tested in clinical laboratories, such as human metapneumovirus (hMPV), human coronavirus (HCoV), and human bocavirus (HBoV).</p><p id="p0115">In this study, we aim to analyze the clinical data of hospitalized children who were febrile and had a RVP test and compare the differences between patients with negative, single and multiple detections for viral pathogens. The viral etiologies contributing to single or multiple infections were compared as well as the data of patients with URTI and LRTI.</p></sec><sec id="sec2"><title>Materials and methods</title><sec id="sec2.1"><title>Patients</title><p id="p0120">We retrospectively reviewed the electronic medical records of hospitalized patients with a report of xTAG RVP from December 30, 2016, to December 31, 2018. Those enrolled patients had fever with or without respiratory symptoms on the general ward or intensive care unit (ICU) of Taipei Veterans General Hospital. RVPs were performed to investigate the possible viral etiology. Of note, three rapid antigen tests, including influenza, respiratory syncytial virus (RSV), and adenovirus (HAdV) were available on the ward. If one of the quick antigen tests came back positive, further RVP test may not be conducted. The clinical characteristics, laboratory data, comorbidities (congenital heart disease, chronic respiratory disease, chronic neurological disease, prematurity, malignancy), clinical diagnosis, duration of antibiotics use, ICU admission and duration hospitalization of the patients were recorded. Patients were divided into three age groups (&#x02264;2 years old; &#x0003e; 2 and&#x000a0;&#x02264;5 years old; &#x0003e;5 years old).</p><p id="p0125">For further comparison of the differences between patients with URTI and LRTI, acute rhinitis, pharyngitis, laryngitis, tonsillitis, otitis media (AOM), acute sinusitis and croup were categorized as URTI whilst LRTI included acute bronchiolitis, bronchitis, and pneumonia. Patients with positive results of <italic>Mycoplasma pneumoniae</italic> serum IgM, urinary pneumococcal antigen, or bacterial culture results from blood, urine, or sputum were recorded as evidence of bacterial infection. This study was approved by the Institutional Review Board of Taipei Veterans General Hospital (No. IRB:2018-02-014AC).</p></sec><sec id="sec2.2"><title>Respiratory virus detection</title><p id="p0130">The extraction of nucleic acids from nasopharyngeal or bronchoalveolar lavage specimens was done using QiaAmp Viral RNA/DNA Mini Kit (QIAGEN, Valencia, CA, USA), according to the manufacturer's instructions. The extracted nucleic acids were immediately frozen at &#x02212;80&#x000a0;&#x000b0;C until further testing. A commercial kit, xTAG RVP Fast Assay, Version 2.0 (Luminex Molecular Diagnosis Inc. Toronto, Canada), was used for respiratory viral detection. xTAG RVP FAST v2 includes two controls (MS-2 and Lambda DNA) to ensure assay performance. This kit allows simultaneous screening for 18 common respiratory viral pathogens and subtypes in the nucleic acid samples, including influenza A virus (Flu A subtype H1, H3, and 2009 H1N1), influenza B virus (Flu B), respiratory syncytial virus (RSV), human coronaviruses (HCoVs, NL63, OC43, 229E, and HKU1), human parainfluenza viruses (PIV) type 1&#x02013;4, human metapneumovirus (hMPV), enteroviruses and rhinoviruses (EV/HRV), human bocavirus (HBoV), and human adenovirus (HAdV). We further differentiated enterovirus from rhinovirus based on the symptoms, signs, and the confirmed diagnosis. The duration of antibiotics treatment and hospitalization were also recorded.</p></sec><sec id="sec2.3"><title>Statistical analysis</title><p id="p0135">The summarized statistical results of the baseline characteristics of the patients were expressed as counts and percentages for categorical data and means with standard deviation. Continuous variables were analyzed using an independent t-test and one-way ANOVA, and categorical variables by the Chi-square test. All comparisons were two-tailed, and P-values less than 0.05 were considered statistically significant. Odds ratios and 95% confidence interval (CI) were calculated by univariate and multivariate logistic regression. All statistical analyses were performed using IBM SPSS Statistics Version 25 (SPSS Inc., Chicago, IL).</p></sec></sec><sec id="sec3"><title>Results</title><p id="p0140">A total of 442 samples were sent for RVP tests from our pediatric ward during the study period with a positive rate of 70%. There were 263 males (59.2%). No mortality was recorded in our study.</p><sec id="sec3.1"><title>Comparison of clinical characteristics, laboratory data and outcome in patients with negative and positive detection for viral pathogens</title><p id="p0145">As shown in <xref rid="tbl1" ref-type="table">Table 1</xref>
, 311 patients (mean age 2.68&#x000a0;&#x000b1;&#x000a0;2.88 years; range 3 days&#x02013;16 years old) had positive detection for viral pathogens in comparison to 131 patients (mean age 4.21&#x000a0;&#x000b1;&#x000a0;5.28 years; range 2 days&#x02013;17 years old) with negative detection. Patients without viral detection were older and had longer duration of fever than those with positive detection for viral pathogens. In multivariable analysis, patients with positive viral detection had significantly lower rate of leukocytosis (p&#x000a0;=&#x000a0;0.03), less evidence of bacterial infection (OR&#x000a0;=&#x000a0;0.420, 95% CI 0.23&#x02013;0.75, p&#x000a0;=&#x000a0;0.004), and shorter duration of hospitalization (OR&#x000a0;=&#x000a0;0.947, 95% CI 0.90&#x02013;0.99, p&#x000a0;=&#x000a0;0.019).<table-wrap position="float" id="tbl1"><label>Table 1</label><caption><p>Comparison of clinical characteristics, laboratory data and outcome in patients with negative &#x00026; positive detection for viral pathogens.</p></caption><alt-text id="alttext0025">Table 1</alt-text><table frame="hsides" rules="groups"><thead><tr><th rowspan="2"/><th rowspan="2">Negative detection for viral pathogens</th><th rowspan="2">Positive detection for viral pathogens</th><th colspan="2">Univariate Analysis<hr/></th><th colspan="2">Multivariable Analysis<xref rid="tbl1fnb" ref-type="table-fn">b</xref><hr/></th></tr><tr><th>OR (95% CI)</th><th>p-value</th><th>aOR (95% CI)</th><th>p-value</th></tr></thead><tbody><tr><td>Number (%)</td><td>131 (29.6%)</td><td>311 (70.4%)</td><td/><td/><td/><td/></tr><tr><td>Gender (% male)</td><td>55.0%</td><td>61.1%</td><td>1.287 (0.85&#x02013;1.94)</td><td>0.231</td><td>1.423 (0.90&#x02013;2.24)</td><td>0.128</td></tr><tr><td><bold>Age (year)</bold></td><td>4.21&#x000a0;&#x000b1;&#x000a0;5.28</td><td>2.68&#x000a0;&#x000b1;&#x000a0;2.88</td><td/><td>0.002*</td><td>0.891 (0.84&#x02013;0.94)</td><td>&#x0003c;0.001*</td></tr><tr><td>&#x02264;2&#x000a0;y/o (n&#x000a0;=&#x000a0;146)</td><td>53.4%</td><td>55.9%</td><td>1.107 (0.73&#x02013;1.66)</td><td>0.627</td><td/><td/></tr><tr><td>&#x0003c;2&#x000a0;&#x0223c;&#x000a0;&#x02264; 5&#x000a0;y/o (n&#x000a0;=&#x000a0;83)</td><td>20.6%</td><td>34.4%</td><td>2.020 (1.24&#x02013;3.27)</td><td>0.004*</td><td/><td/></tr><tr><td>&#x0003e;5&#x000a0;y/o (n&#x000a0;=&#x000a0;19)</td><td>26.0%</td><td>9.6%</td><td>0.305 (0.17&#x02013;0.52)</td><td>&#x0003c;0.001*</td><td/><td/></tr><tr><td colspan="7"><bold>Symptoms</bold></td></tr><tr><td>Fever duration (d)</td><td>5.17&#x000a0;&#x000b1;&#x000a0;10.04</td><td>4.23&#x000a0;&#x000b1;&#x000a0;3.94</td><td/><td>0.303</td><td>1.020 (0.98&#x02013;1.05)</td><td>0.270</td></tr><tr><td colspan="7"><bold>Lab data</bold></td></tr><tr><td>WBC (/ul)</td><td>13,146&#x000a0;&#x000b1;&#x000a0;8567</td><td>11,017&#x000a0;&#x000b1;&#x000a0;5170</td><td/><td>0.001*</td><td>1.000 (1.00&#x02013;1.00)</td><td>0.030*</td></tr><tr><td>CRP (mg/dl)</td><td>3.42&#x000a0;&#x000b1;&#x000a0;4.17</td><td>2.28&#x000a0;&#x000b1;&#x000a0;3.87</td><td/><td>0.016*</td><td>0.992 (0.93&#x02013;1.05)</td><td>0.779</td></tr><tr><td>Evidence of bacterial infection<xref rid="tbl1fna" ref-type="table-fn">a</xref></td><td>29.0%</td><td>11.6%</td><td>0.320 (0.19&#x02013;0.53)</td><td>&#x0003c;0.001*</td><td>0.420 (0.23&#x02013;0.75)</td><td>0.004*</td></tr><tr><td colspan="7"><bold>Outcome</bold></td></tr><tr><td>Antibiotic treatment duration (d)</td><td>5.52&#x000a0;&#x000b1;&#x000a0;5.73</td><td>3.04&#x000a0;&#x000b1;&#x000a0;4.88</td><td/><td>&#x0003c;0.001*</td><td>1.009 (0.94&#x02013;1.08)</td><td>0.805</td></tr><tr><td>ICU admission (%)</td><td>34.4%</td><td>17.4%</td><td>0.402 (0.25&#x02013;0.63)</td><td>&#x0003c;0.001*</td><td>0.822 (0.44&#x02013;1.52)</td><td>0.531</td></tr><tr><td>Hospitalization duration (d)</td><td>11.09&#x000a0;&#x000b1;&#x000a0;13.99</td><td>5.53&#x000a0;&#x000b1;&#x000a0;5.64</td><td/><td>&#x0003c;0.001*</td><td>0.947 (0.90&#x02013;0.99)</td><td>0.019*</td></tr></tbody></table><table-wrap-foot><fn id="tspara0015"><p>Mean&#x000a0;&#x000b1;&#x000a0;SD; OR&#x000a0;=&#x000a0;Odds ratio; aOR&#x000a0;=&#x000a0;adjusted Odds ratio; CI&#x000a0;=&#x000a0;confidence interval; d&#x000a0;=&#x000a0;day; WBC&#x000a0;=&#x000a0;white blood cell; CRP&#x000a0;=&#x000a0;C-reactive protein; ICU&#x000a0;=&#x000a0;intensive care unit.</p></fn><fn id="tspara0020"><p>*p&#x000a0;&#x0003c;&#x000a0;0.05.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tbl1fna"><label>a</label><p id="ntpara0010">Positive results of <italic>Mycoplasma pneumoniae</italic> serum IgM, urine pneumococcal antigen, or bacterial culture from blood, urine, or sputum.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tbl1fnb"><label>b</label><p id="ntpara0015">Adjusted with comorbidity (congenital heart disease, chronic respiratory disease, chronic neurological disease, prematurity, malignancy).</p></fn></table-wrap-foot></table-wrap></p></sec><sec id="sec3.2"><title>Comparison between single and multiple viral infections</title><p id="p0150">The clinical characteristics, laboratory data and outcome of patients with single and multiple viral infections were compared (<xref rid="tbl2" ref-type="table">Table 2</xref>
). Multiple viral infections accounted for 27% (83/311) of patients with a positive RVP report whereas 228 patients had single viral detection. To minimize the confounding effects of bacterial infection on outcome analysis, we excluded patients with AOM, acute sinusitis, and evidence of bacterial infection. As a result, the clinical data of 188 patients with single viral infection and 69 patients with multiple viral infections were compared. Using a multivariable logistic regression model with adjustment by comorbidity, patients with multiple viral infections were younger (OR&#x000a0;=&#x000a0;0.812, 95% CI 0.70&#x02013;0.96, p&#x000a0;=&#x000a0;0.015) than those with single viral infection. Interestingly, there was no statistically significant difference in the duration of fever, antibiotics treatment and hospitalization between patients with single and multiple viral infections.<table-wrap position="float" id="tbl2"><label>Table 2</label><caption><p>Comparison of clinical data and outcome between patients with single and multiple viral infections.</p></caption><alt-text id="alttext0030">Table 2</alt-text><table frame="hsides" rules="groups"><thead><tr><th rowspan="2"/><th rowspan="2">Single viral infection</th><th rowspan="2">Multiple viral infections</th><th colspan="2">Univariate Analysis<hr/></th><th colspan="2">Multivariable Analysis<xref rid="tbl2fna" ref-type="table-fn">a</xref><hr/></th></tr><tr><th>OR (95% CI)</th><th>p-value</th><th>aOR (95% CI)</th><th>p-value</th></tr></thead><tbody><tr><td>Number (%)</td><td>188 (73%)</td><td>69 (27%)</td><td/><td/><td/><td/></tr><tr><td>Gender (male %)</td><td>58.6%</td><td>63.8%</td><td>1.248 (0.70&#x02013;2.20)</td><td>0.446</td><td>1.233 (0.68&#x02013;2.23)</td><td>0.490</td></tr><tr><td><bold>Age (year)</bold></td><td>2.76&#x000a0;&#x000b1;&#x000a0;3.06</td><td>1.85&#x000a0;&#x000b1;&#x000a0;1.65</td><td/><td>0.003*</td><td>0.821 (0.70&#x02013;0.96)</td><td>0.015*</td></tr><tr><td>&#x02264;2&#x000a0;y/o (n&#x000a0;=&#x000a0;146)</td><td>55.8%</td><td>67.2%</td><td>1.547 (0.87&#x02013;2.74)</td><td>0.134</td><td/><td/></tr><tr><td>&#x0003c;2&#x000a0;&#x0223c;&#x000a0;&#x02264; 5&#x000a0;y/o (n&#x000a0;=&#x000a0;83)</td><td>34.6%</td><td>33.3%</td><td>0.946 (0.52&#x02013;1.69)</td><td>0.853</td><td/><td/></tr><tr><td>&#x0003e;5&#x000a0;y/o (n&#x000a0;=&#x000a0;19)</td><td>10.6%</td><td>1.4%</td><td>0.124 (0.01&#x02013;0.93)</td><td>0.017*</td><td/><td/></tr><tr><td colspan="7"><bold>Symptoms</bold></td></tr><tr><td>Fever duration (d)</td><td>3.84&#x000a0;&#x000b1;&#x000a0;3.00</td><td>3.68&#x000a0;&#x000b1;&#x000a0;2.24</td><td/><td>0.698</td><td>1.011 (0.90&#x02013;1.13)</td><td>0.852</td></tr><tr><td colspan="7"><bold>Lab data</bold></td></tr><tr><td>WBC (/ul)</td><td>10,498&#x000a0;&#x000b1;&#x000a0;4814</td><td>11,751&#x000a0;&#x000b1;&#x000a0;5390</td><td/><td>0.075</td><td>1.000 (1.00&#x02013;1.00)</td><td>0.106</td></tr><tr><td>CRP (mg/dl)</td><td>1.77&#x000a0;&#x000b1;&#x000a0;3.14</td><td>2.29&#x000a0;&#x000b1;&#x000a0;3.36</td><td/><td>0.249</td><td>1.082 (0.98&#x02013;1.19)</td><td>0.114</td></tr><tr><td>Antibiotic treatment duration (d)</td><td>2.43&#x000a0;&#x000b1;&#x000a0;3.59</td><td>2.33&#x000a0;&#x000b1;&#x000a0;2.68</td><td/><td>0.837</td><td>1.042 (0.90&#x02013;1.19)</td><td>0.561</td></tr><tr><td colspan="7"><bold>Outcome</bold></td></tr><tr><td>ICU admission (%)</td><td>19.7%</td><td>13.0%</td><td>0.612 (0.27&#x02013;1.34)</td><td>0.219</td><td>0.515 (0.20&#x02013;1.29)</td><td>0.157</td></tr><tr><td>Hospitalization duration (d)</td><td>5.12&#x000a0;&#x000b1;&#x000a0;4.49</td><td>4.67&#x000a0;&#x000b1;&#x000a0;2.73</td><td/><td>0.435</td><td>0.964 (0.84&#x02013;1.09)</td><td>0.575</td></tr></tbody></table><table-wrap-foot><fn id="tspara0030"><p>Mean&#x000a0;&#x000b1;&#x000a0;SD; OR&#x000a0;=&#x000a0;Odds ratio; aOR&#x000a0;=&#x000a0;adjusted Odds ratio; CI&#x000a0;=&#x000a0;confidence interval; d&#x000a0;=&#x000a0;day; WBC&#x000a0;=&#x000a0;white blood cell; CRP = C-reactive protein; ICU&#x000a0;=&#x000a0;intensive care unit.</p></fn><fn id="tspara0035"><p>*p&#x000a0;&#x0003c;&#x000a0;0.05.</p></fn><fn id="tspara0040"><p>We excluded patients with AOM, acute sinusitis, and evidence of bacterial infection.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tbl2fna"><label>a</label><p id="ntpara0020">Adjusted with comorbidity (congenital heart disease, chronic respiratory disease, chronic neurological disease, prematurity, malignancy).</p></fn></table-wrap-foot></table-wrap></p></sec><sec id="sec3.3"><title>Number of identified viruses and their presence in multiple viral infections</title><p id="p0155">As shown in <xref rid="fig1" ref-type="fig">Fig.&#x000a0;1</xref>
, HRVs (36%, n&#x000a0;=&#x000a0;113) are the most commonly identified virus among all the 311 patients, followed by RSVs (28%, n&#x000a0;=&#x000a0;88), and PIVs (22%, n&#x000a0;=&#x000a0;70). Notably, HBoV was detected mainly in multiple viral infections (79%, 19/24), followed by HAdV (62%, 18/29) and HRV (49%, 56/113). Among the 83 patients with multiple viral infections, the most common combination of viral infections was RSV&#x000a0;+&#x000a0;HRV 20.4% (17/83), followed by HRV&#x000a0;+&#x000a0;HBoV 8.4% (7/83) and HAdV&#x000a0;+&#x000a0;HRV 8.4% (7/83) (<xref rid="appsec1" ref-type="sec">Supplemental Table 1</xref>). Moreover, dual viral pathogens were detected in 23.1% (72/311) patients with viral infections, triple in 2.2% (7/311) and quadruple in 1.2% (4/311) of patients.<fig id="fig1"><label>Figure&#x000a0;1</label><caption><p>The number of identified viruses and their presence in multiple viral infections. Blue bars denote the number of each identified virus. Orange bars show the frequency of each virus present in multiple viral infections. PIV includes PIV1 (n&#x000a0;=&#x000a0;25), PIV3 (n&#x000a0;=&#x000a0;38), PIV4 (n&#x000a0;=&#x000a0;6) and non-typable PIV (n&#x000a0;=&#x000a0;1).</p></caption><alt-text id="alttext0020">Figure&#x000a0;1</alt-text><graphic xlink:href="gr1_lrg"/></fig></p></sec><sec id="sec3.4"><title>Clinical characteristics, laboratory data, clinical diagnosis and outcome of patients with single viral infection</title><p id="p0160">Next, we analyzed the clinical data of patients with single virus infection (<xref rid="appsec1" ref-type="sec">Supplemental Table 2</xref>). To minimize the confounding effects of bacterial infection on outcome analysis, patients with AOM, acute sinusitis and evidence of bacterial infection were excluded. As a result, HAdV infection was noted more in older children (5.65&#x000a0;&#x000b1;&#x000a0;3.56 years) whilst HBoV infected patients at a younger age (0.88&#x000a0;&#x000b1;&#x000a0;0.09 years). Moreover, patients infected with HAdV had a longer duration of fever (5.60&#x000a0;&#x000b1;&#x000a0;0.54 days) in comparison to the shorter duration of fever (2.00&#x000a0;&#x000b1;&#x000a0;1.00 days) caused by HBoV infection. Notably, HAdV infection raised a higher C-reactive protein (CRP) level (3.53&#x000a0;&#x000b1;&#x000a0;4.51&#x000a0;mg/dL). There was no single viral pathogen correlating with longer antibiotics treatment, more ICU admission or longer duration of hospitalization.</p></sec><sec id="sec3.5"><title>Comparison of clinical data, viral etiologies and outcome between patients with URTI and LRTI</title><p id="p0165">We further compared the clinical characteristics, laboratory data, clinical diagnosis, and outcome between URTI and LTRI groups (<xref rid="tbl3" ref-type="table">Table 3</xref>
). After patients with AOM, acute sinusitis, herpangina and evidence of bacterial infection were excluded from analysis, there were 58 and 167 patients in URTI and LRTI groups, respectively. Using multivariable logistic regression with comorbidity adjustment, we identified three factors independently associated with LRTI, including multiple viral infections (OR&#x000a0;=&#x000a0;2.996, 95% CI 1.17&#x02013;7.65, p&#x000a0;=&#x000a0;0.022), RSV infection (OR&#x000a0;=&#x000a0;6.477, 95% CI 2.17&#x02013;19.27, p&#x000a0;=&#x000a0;0.001), longer hospitalization duration (OR&#x000a0;=&#x000a0;1.306, 95% CI 1.06&#x02013;1.60, p&#x000a0;=&#x000a0;0.011). By contrast, Flu-B infection (OR&#x000a0;=&#x000a0;0.060, 95% CI 0.006&#x02013;0.57, p&#x000a0;=&#x000a0;0.015) and HCoV infection (OR&#x000a0;=&#x000a0;0.255, 95% CI 0.06&#x02013;0.96, p&#x000a0;=&#x000a0;0.044) were independently associated with URTI. There was no statistical difference in duration of fever, CRP level, and duration of antibiotics treatment between URTI and LRTI infections.<table-wrap position="float" id="tbl3"><label>Table 3</label><caption><p>Comparison of clinical data, viral etiologies and outcome between patients with upper and lower respiratory tract infection.</p></caption><alt-text id="alttext0035">Table 3</alt-text><table frame="hsides" rules="groups"><thead><tr><th rowspan="2"/><th rowspan="2">URTI<xref rid="tbl3fna" ref-type="table-fn">a</xref></th><th rowspan="2">LRTI<xref rid="tbl3fnb" ref-type="table-fn">b</xref></th><th colspan="2">Univariate Analysis<hr/></th><th colspan="2">Multivariable Analysis<xref rid="tbl3fnc" ref-type="table-fn">c</xref><hr/></th></tr><tr><th>OR (95% CI)</th><th>p-value</th><th>aOR (95% CI)</th><th>p-value</th></tr></thead><tbody><tr><td>Number, n</td><td>58</td><td>167</td><td/><td/><td/><td/></tr><tr><td>Gender (Male: female)</td><td>55.2%</td><td>62.3%</td><td>1.341 (0.73&#x02013;2.45)</td><td>0.341</td><td>1.721 (0.83&#x02013;3.53)</td><td>0.140</td></tr><tr><td><bold>Age (year)</bold></td><td>2.73&#x000a0;&#x000b1;&#x000a0;2.79</td><td>2.36&#x000a0;&#x000b1;&#x000a0;2.53</td><td/><td>0.357</td><td>0.987 (0.85&#x02013;1.13)</td><td>0.860</td></tr><tr><td>&#x02264;2&#x000a0;y/o (%)</td><td>56.9%</td><td>58.1%</td><td>1.050 (0.57&#x02013;1.92)</td><td>0.875</td><td/><td/></tr><tr><td>&#x0003e;2&#x000a0;y/o&#x000a0;&#x0223c;&#x000a0;&#x02264; 5&#x000a0;y/o (%)</td><td>32.8%</td><td>35.3%</td><td>1.121 (0.59&#x02013;2.11)</td><td>0.723</td><td/><td/></tr><tr><td>&#x0003e;5&#x000a0;y/o (%)</td><td>10.3%</td><td>6.6%</td><td>0.611 (0.21&#x02013;1.73)</td><td>0.351</td><td/><td/></tr><tr><td colspan="7"><bold>Pathogen</bold></td></tr><tr><td>Multiple viral infections (%)</td><td>15.5%</td><td>30.5%</td><td>2.394 (1.09&#x02013;5.23)</td><td>0.026*</td><td>2.996 (1.17&#x02013;7.65)</td><td>0.022*</td></tr><tr><td>HAdV (%)</td><td>10.3%</td><td>7.8%</td><td>0.732 (0.26&#x02013;2.02)</td><td>0.546</td><td/><td/></tr><tr><td>Flu A (%)</td><td>8.6%</td><td>1.8%</td><td>0.194 (0.04&#x02013;0.83)</td><td>0.016*</td><td>0.189 (0.03&#x02013;1.08)</td><td>0.061</td></tr><tr><td>Flu B (%)</td><td>5.2%</td><td>1.2%</td><td>0.222 (0.03&#x02013;1.36)</td><td>0.077</td><td>0.060 (0.006&#x02013;0.57)</td><td>0.015*</td></tr><tr><td>PIV (%)</td><td>32.8%</td><td>19.8%</td><td>0.505 (0.25&#x02013;0.98)</td><td>0.043*</td><td>0.620 (0.27&#x02013;1.41)</td><td>0.258</td></tr><tr><td>PIV1 (%)</td><td>15.5%</td><td>6.6%</td><td>0.384 (0.15&#x02013;0.98)</td><td>0.040*</td><td/><td/></tr><tr><td>PIV3 (%)</td><td>17.2%</td><td>10.8%</td><td>0.580 (0.25&#x02013;1.34)</td><td>0.199</td><td/><td/></tr><tr><td>PIV4 (%)</td><td>1.7%</td><td>1.8%</td><td>1.043 (0.10&#x02013;10.2)</td><td>0.971</td><td/><td/></tr><tr><td>hMPV (%)</td><td>3.4%</td><td>6.0%</td><td>1.783 (0.37&#x02013;8.39)</td><td>0.458</td><td/><td/></tr><tr><td>HCoV (%)</td><td>12.1%</td><td>4.2%</td><td>0.319 (0.10&#x02013;0.95)</td><td>0.032*</td><td>0.255 (0.06&#x02013;0.96)</td><td>0.044*</td></tr><tr><td>RSV (%)</td><td>8.6%</td><td>41.3%</td><td>7.463 (2.83&#x02013;19.6)</td><td>&#x0003c;0.001*</td><td>6.477 (2.17&#x02013;19.27)</td><td>0.001*</td></tr><tr><td>HRV (%)</td><td>34.5%</td><td>41.9%</td><td>1.371 (0.73&#x02013;2.55)</td><td>0.319</td><td/><td/></tr><tr><td>EV (%)</td><td>1.7%</td><td>0.0%</td><td/><td>0.089</td><td/><td/></tr><tr><td>HBoV (%)</td><td>5.2%</td><td>8.4%</td><td>1.678 (0.46&#x02013;6.06)</td><td>0.425</td><td/><td/></tr><tr><td colspan="7"><bold>Symptoms</bold></td></tr><tr><td>Fever duration (d)</td><td>3.93&#x000a0;&#x000b1;&#x000a0;3.41</td><td>3.89&#x000a0;&#x000b1;&#x000a0;2.72</td><td/><td>0.931</td><td/><td/></tr><tr><td colspan="7"><bold>Lab data</bold></td></tr><tr><td>WBC (/ul)</td><td>11,307&#x000a0;&#x000b1;&#x000a0;5738</td><td>10,743&#x000a0;&#x000b1;&#x000a0;4856</td><td/><td>0.469</td><td/><td/></tr><tr><td>CRP (mg/dl)</td><td>2.03&#x000a0;&#x000b1;&#x000a0;2.87</td><td>1.97&#x000a0;&#x000b1;&#x000a0;3.40</td><td/><td>0.907</td><td>0.985 (0.87&#x02013;1.10)</td><td>0.798</td></tr><tr><td colspan="7"><bold>Outcome</bold></td></tr><tr><td>Antibiotic treatment duration (d)</td><td>1.52&#x000a0;&#x000b1;&#x000a0;2.28</td><td>2.53&#x000a0;&#x000b1;&#x000a0;3.56</td><td/><td>0.044*</td><td/><td/></tr><tr><td>ICU admission (%)</td><td>5.2%</td><td>18.6%</td><td>4.179 (1.22&#x02013;14.2)</td><td>0.014*</td><td>3.308 (0.82&#x02013;13.28)</td><td>0.092</td></tr><tr><td>Hospitalization duration (d)</td><td>3.53&#x000a0;&#x000b1;&#x000a0;1.76</td><td>5.08&#x000a0;&#x000b1;&#x000a0;4.36</td><td/><td>0.009*</td><td>1.306 (1.06&#x02013;1.60)</td><td>0.011*</td></tr></tbody></table><table-wrap-foot><fn id="tspara0050"><p>Mean&#x000a0;&#x000b1;&#x000a0;Standard deviation; OR&#x000a0;=&#x000a0;Odds ratio; aOR&#x000a0;=&#x000a0;adjusted Odds ratio; CI&#x000a0;=&#x000a0;confidence interval; d&#x000a0;=&#x000a0;day; URTI&#x000a0;=&#x000a0;upper respiratory tract infection; LRTI&#x000a0;=&#x000a0;lower respiratory tract infection; WBC&#x000a0;=&#x000a0;white blood cell; CRP&#x000a0;=&#x000a0;C-reactive protein; ICU&#x000a0;=&#x000a0;intensive care unit.</p></fn><fn id="tspara0055"><p>*p&#x000a0;&#x0003c;&#x000a0;0.05.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tbl3fna"><label>a</label><p id="ntpara0025">We excluded patients with AOM, acute sinusitis, herpangina and evidence of bacterial infection.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tbl3fnb"><label>b</label><p id="ntpara0030">We excluded patients with evidence of bacterial infection.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tbl3fnc"><label>c</label><p id="ntpara0035">Adjusted with comorbidity (congenital heart disease, chronic respiratory disease, chronic neurological disease, prematurity, malignancy).</p></fn></table-wrap-foot></table-wrap></p></sec></sec><sec id="sec4"><title>Discussion</title><p id="p0170">In the present study, we analyzed the data of 442 hospitalized children who were febrile and had the xTAG RVP test in a single medical center over a 2-year period. Patients with negative detection for viral pathogens had more evidence of bacterial infection, higher white blood cell count and longer duration of hospitalization in comparison to patients with positive detection for viral pathogens.</p><p id="p0175">The age of patients with multiple viral infections was younger than those with single viral infection. Nevertheless, there was no difference in duration of fever and the clinical outcome, including duration of antibiotics treatment and hospital stay, between these two groups of patients. These findings are consistent with recent systematic reviews and meta-analyses which have concluded that there was no significant difference between children with single and multiple respiratory viral infections concerning the clinical disease severity, the length of hospital stay, admission to the intensive care unit, need for mechanical ventilation, oxygen requirements, and death.<xref rid="bib11" ref-type="bibr"><sup>11</sup></xref>
<sup>,</sup>
<xref rid="bib16" ref-type="bibr"><sup>16</sup></xref>
<sup>,</sup>
<xref rid="bib17" ref-type="bibr"><sup>17</sup></xref> By contrast, some studies showed that multiple viral infections increased the risk of ICU admission.<xref rid="bib18" ref-type="bibr"><sup>18</sup></xref>
</p><p id="p0180">Of note, the simultaneous detection of multiple viruses does not necessarily implicate the pathogenic effect at the time of detection, especially when molecular methods are used. It is also difficult to distinguish between active viral infection, viral shedding, and potentially non-pathogenic viral infection. For instance, HBoV and HAdV may have prolonged viral shedding.<xref rid="bib11" ref-type="bibr"><sup>11</sup></xref> The detection of two viruses may represent an episode of acute infection in the presence of other viral persistence from a recent infection.<xref rid="bib19" ref-type="bibr"><sup>19</sup></xref> Moreover, the mechanisms of disease virulence and viral&#x02013;viral interaction in multiple infections are not clearly understood. They may result from direct interactions of viral genes or indirect interactions resulting from alterations in the host-environment or immunological interactions.<xref rid="bib20" ref-type="bibr"><sup>20</sup></xref> Different pathogenic mechanisms may be triggered by different viruses, which may potentiate or inhibit the effects on each other. For instance, RSV or influenza coinfection with other viruses may associate with a worse outcome.<xref rid="bib7" ref-type="bibr"><sup>7</sup></xref>
<sup>,</sup>
<xref rid="bib21" ref-type="bibr"><sup>21</sup></xref> Furthermore, some studies indicated a high viral load is related to higher disease severity in respiratory infections<xref rid="bib22" ref-type="bibr"><sup>22</sup></xref>; however, conflicting results have been reported.<xref rid="bib23" ref-type="bibr"><sup>23</sup></xref> Therefore, further studies are needed to determine whether multiple viral infections contribute to disease severity.</p><p id="p0185">Of all the respiratory viruses analyzed, HRV, RSV, and PIV were the most commonly identified viruses in descending order. Previous studies have shown slightly different rankings of common respiratory pathogens; nevertheless, HRV has consistently been the most common cause in all age groups.<xref rid="bib24" ref-type="bibr"><sup>24</sup></xref> Similar to results of previous studies, RSV and PIV are the most common cause of lower respiratory tract infections in infants and young children.<xref rid="bib25" ref-type="bibr"><sup>25</sup></xref>
<sup>,</sup>
<xref rid="bib26" ref-type="bibr"><sup>26</sup></xref> HAdV is accountable for around 10 percent of ARTI in children in the previous study<xref rid="bib5" ref-type="bibr"><sup>5</sup></xref> and it was 9% in our study. This was underestimated because patients with a positive quick adenovirus antigen test without proceeding to have xTAG RVP testing were not included in our analysis. Six percent (19/311) of children were reported positive for HCoV, of which 2.5% were positive for OC43 (8/311), 2.2% for NL63 (7/311), 0.6% for 229E (2/311), and 0.6% for HKU1 (2/311). These are similar to previous results.<xref rid="bib27" ref-type="bibr"><sup>27</sup></xref>
</p><p id="p0190">In this study, 27% of children had multiple viral infections. The result is similar to the previous studies that detection of multiple viruses simultaneously in pediatric patients ranges from 10 to 30%.<xref rid="bib28" ref-type="bibr"><sup>28</sup></xref> Similar to previous findings, the three most commonly detected viruses in multiple viral infections were HRV, RSV, and PIV in this study.<xref rid="bib10" ref-type="bibr"><sup>10</sup></xref>
<sup>,</sup>
<xref rid="bib29" ref-type="bibr"><sup>29</sup></xref> Furthermore, higher percentages of HBoV (79%), HAdV (62%), and HRV (49%) infection were present in children with multiple viral infections. Previous studies showed that around 33%&#x02013;75% of HBoV was detected in children who had co-infection with other viruses.<xref rid="bib30" ref-type="bibr"><sup>30</sup></xref>
<sup>,</sup>
<xref rid="bib31" ref-type="bibr"><sup>31</sup></xref> According to the previous study by Lee et&#x000a0;al., multiple respiratory viral infections with HAdV were reported in 30.5% of children.<xref rid="bib32" ref-type="bibr"><sup>32</sup></xref> HRV was the most common co-infecting virus which occurring in 69.6% of multiple viral infections.<xref rid="bib33" ref-type="bibr"><sup>33</sup></xref> In addition, the most common combinations of multiple viral infections were HRV&#x000a0;+&#x000a0;RSV and HRV&#x000a0;+&#x000a0;HAdV and triple/quadruple viral infections accounted for a certain proportion similar to the results of previous studies.<xref rid="bib11" ref-type="bibr"><sup>11</sup></xref>
<sup>,</sup>
<xref rid="bib33" ref-type="bibr">33</xref>, <xref rid="bib34" ref-type="bibr">34</xref>, <xref rid="bib35" ref-type="bibr">35</xref>
</p><p id="p0195">HBoV infections occurred mostly in children less than 2 years of age with a mean age of 0.88&#x000a0;&#x000b1;&#x000a0;0.09 years. The previous study indicated that HBoV circulates in the community and is acquired early in life.<xref rid="bib36" ref-type="bibr"><sup>36</sup></xref> The clinical picture of adenovirus infection was characterized by high grade and prolonged fever. Laboratory findings of HAdV infections include elevated CRP, leukocytosis, and neutrophilia.<xref rid="bib37" ref-type="bibr"><sup>37</sup></xref> In our study, HAdV had significantly longer fever duration (5.60&#x000a0;&#x000b1;&#x000a0;0.54 days) and elevated CRP level (3.53&#x000a0;&#x000b1;&#x000a0;4.51&#x000a0;mg/dl).</p><p id="p0200">Flu-B infection and HCoV infection were independently associated with URTI whereas multiple viral infections, RSV infection, and longer hospitalization duration were independently associated with LRTI. To minimize the confounding effects of concurrent bacterial infection, we excluded patients with AOM, acute sinusitis, and evidence of bacterial infection. Those patients with a positive influenza antigen test were not enrolled for analysis so the case number was small. Previous studies have shown four subtypes of HCoV (OC43, 229E, NL63, HKU1) lead to milder URTI.<xref rid="bib38" ref-type="bibr"><sup>38</sup></xref> On the other hand, RSV has been reported as the primary pathogen causing LRTI and hospitalization in young children.<xref rid="bib39" ref-type="bibr"><sup>39</sup></xref> In our study, 90% of patients with positive RSV detection had acute bronchiolitis or pneumonia.</p><p id="p0205">There were several limitations to this study. Firstly, those who had a positive quick antigen test result without RVP testing were not included. That could explain why the numbers of cases with adenovirus, RSV and influenza infections were smaller in comparison to previous studies.<xref rid="bib5" ref-type="bibr"><sup>5</sup></xref>
<sup>,</sup>
<xref rid="bib29" ref-type="bibr"><sup>29</sup></xref> Secondly, the RVP was not a timely test as it might take days to obtain the result. The delay might have contributed to the prolonged course of antibiotics use or lengthened hospital course due to fever. Thirdly, patients with bacterial co-infection but without evidence potentially have a confounding influence on the outcome analysis.</p><p id="p0210">In conclusion, the RVP has unveiled many viral pathogens that have not been routinely detected or cultured in clinical settings. In comparison to patients with negative detection for viral pathogens, those with positive detection for viral pathogens had significantly lower rates of leukocytosis, evidence of bacterial infection, and shorter duration of hospitalization. Multiple viral infections were more common in younger children and did not predict a worse outcome such as duration of fever and hospitalization. The most common identified virus remained HRV whilst HBoV was present in a high percentage in multiple viral infections. Moreover, LRTI was independently associated with multiple viral infections, RSV infection and longer hospitalization duration. Further studies on the pathogenesis, disease severity and outcome of different viral combinations are needed to clarify the interplay of host and viruses in multiple viral infections.</p></sec><sec id="sec5"><title>Funding source</title><p id="p0215">No funding was secured for this study.</p></sec><sec id="sec6"><title>Financial disclosure</title><p id="p0220">All authors have no financial relationships relevant to this article to disclose.</p></sec><sec id="sec7"><title>Contributors' statement</title><p id="p0225">C.-Y. Yen, Y.-J. Chan, K.-G. Wu and M.-C. Hung conceived the idea of this study and designed the study. C.-Y. Yen and W.-T. Wu conducted data acquisition and performed statistical analysis. C.-Y. Yen, C.-Y. Chang, Y.-C. Wong and C.-C. Lai drafted the initial manuscript. C.-Y. Yen K.-G. Wu and M.-C. Hung critically revised the manuscript. All authors approved the final version of the manuscript as submitted and agree to be accountable for all aspects of the work.</p></sec><sec sec-type="COI-statement"><title>Declaration of Competing Interest</title><p id="p0230">All authors have no conflicts of financial and non-financial interest to disclose.</p></sec></body><back><ref-list id="cebib0010"><title>References</title><ref id="bib1"><label>1</label><element-citation publication-type="journal" id="sref1"><person-group person-group-type="author"><name><surname>Berman</surname><given-names>S.</given-names></name></person-group><article-title>Epidemiology of acute respiratory infections in children of developing countries</article-title><source>Rev Infect Dis</source><volume>13</volume><issue>Suppl 6</issue><year>1991</year><fpage>S454</fpage><lpage>S462</lpage><pub-id pub-id-type="pmid">1862276</pub-id></element-citation></ref><ref id="bib2"><label>2</label><element-citation publication-type="journal" id="sref2"><person-group person-group-type="author"><name><surname>Monto</surname><given-names>A.S.</given-names></name></person-group><article-title>Studies of the community and family: acute respiratory illness and infection</article-title><source>Epidemiol Rev</source><volume>16</volume><issue>2</issue><year>1994</year><fpage>351</fpage><lpage>373</lpage><pub-id pub-id-type="pmid">7713184</pub-id></element-citation></ref><ref id="bib3"><label>3</label><element-citation publication-type="journal" id="sref3"><person-group person-group-type="author"><name><surname>Mortality</surname><given-names>G.B.D.</given-names></name></person-group><article-title>Causes of Death C. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013</article-title><source>Lancet</source><volume>385</volume><issue>9963</issue><year>2015</year><fpage>117</fpage><lpage>171</lpage><pub-id pub-id-type="pmid">25530442</pub-id></element-citation></ref><ref id="bib4"><label>4</label><element-citation publication-type="journal" id="sref4"><person-group person-group-type="author"><name><surname>van Houten</surname><given-names>C.B.</given-names></name><name><surname>Cohen</surname><given-names>A.</given-names></name><name><surname>Engelhard</surname><given-names>D.</given-names></name><name><surname>Hays</surname><given-names>J.P.</given-names></name><name><surname>Karlsson</surname><given-names>R.</given-names></name><name><surname>Moore</surname><given-names>E.</given-names></name></person-group><article-title>Antibiotic misuse in respiratory tract infections in children and adults-a prospective, multicentre study (TAILORED Treatment)</article-title><source>Eur J Clin Microbiol Infect Dis &#x02013; Offic Public Eur Soc Clin Microbiol</source><volume>38</volume><issue>3</issue><year>2019</year><fpage>505</fpage><lpage>514</lpage></element-citation></ref><ref id="bib5"><label>5</label><element-citation publication-type="book" id="sref5"><person-group person-group-type="author"><name><surname>Galanti</surname><given-names>M.</given-names></name><name><surname>Birger</surname><given-names>R.</given-names></name><name><surname>Ud-Dean</surname><given-names>M.</given-names></name><name><surname>Filip</surname><given-names>I.</given-names></name><name><surname>Morita</surname><given-names>H.</given-names></name><name><surname>Comito</surname><given-names>D.</given-names></name></person-group><chapter-title>Longitudinal active sampling for respiratory viral infections across age groups</chapter-title><year>2019</year><publisher-name>Influenza Other Respir Viruses</publisher-name></element-citation></ref><ref id="bib6"><label>6</label><element-citation publication-type="journal" id="sref6"><person-group person-group-type="author"><name><surname>Chauhan</surname><given-names>J.C.</given-names></name><name><surname>Slamon</surname><given-names>N.B.</given-names></name></person-group><article-title>The impact of multiple viral respiratory infections on outcomes for critically Ill children</article-title><source>Pediatr Crit Care Med &#x02013; J Soc Crit Care Med World Fed Pediatr Intensive Crit Care Soc</source><volume>18</volume><issue>8</issue><year>2017</year><fpage>e333</fpage><lpage>e338</lpage></element-citation></ref><ref id="bib7"><label>7</label><element-citation publication-type="journal" id="sref7"><person-group person-group-type="author"><name><surname>Cilla</surname><given-names>G.</given-names></name><name><surname>Onate</surname><given-names>E.</given-names></name><name><surname>Perez-Yarza</surname><given-names>E.G.</given-names></name><name><surname>Montes</surname><given-names>M.</given-names></name><name><surname>Vicente</surname><given-names>D.</given-names></name><name><surname>Perez-Trallero</surname><given-names>E.</given-names></name></person-group><article-title>Viruses in community-acquired pneumonia in children aged less than 3 years old: high rate of viral coinfection</article-title><source>J Med Virol</source><volume>80</volume><issue>10</issue><year>2008</year><fpage>1843</fpage><lpage>1849</lpage><pub-id pub-id-type="pmid">18712820</pub-id></element-citation></ref><ref id="bib8"><label>8</label><element-citation publication-type="journal" id="sref8"><person-group person-group-type="author"><name><surname>Richard</surname><given-names>N.</given-names></name><name><surname>Komurian-Pradel</surname><given-names>F.</given-names></name><name><surname>Javouhey</surname><given-names>E.</given-names></name><name><surname>Perret</surname><given-names>M.</given-names></name><name><surname>Rajoharison</surname><given-names>A.</given-names></name><name><surname>Bagnaud</surname><given-names>A.</given-names></name></person-group><article-title>The impact of dual viral infection in infants admitted to a pediatric intensive care unit associated with severe bronchiolitis</article-title><source>Pediatr Infect Dis J</source><volume>27</volume><issue>3</issue><year>2008</year><fpage>213</fpage><lpage>217</lpage><pub-id pub-id-type="pmid">18277932</pub-id></element-citation></ref><ref id="bib9"><label>9</label><element-citation publication-type="journal" id="sref9"><person-group person-group-type="author"><name><surname>Wishaupt</surname><given-names>J.O.</given-names></name><name><surname>van der Ploeg</surname><given-names>T.</given-names></name><name><surname>de Groot</surname><given-names>R.</given-names></name><name><surname>Versteegh</surname><given-names>F.G.</given-names></name><name><surname>Hartwig</surname><given-names>N.G.</given-names></name></person-group><article-title>Single- and multiple viral respiratory infections in children: disease and management cannot be related to a specific pathogen</article-title><source>BMC Infect Dis</source><volume>17</volume><issue>1</issue><year>2017</year><fpage>62</fpage><pub-id pub-id-type="pmid">28077074</pub-id></element-citation></ref><ref id="bib10"><label>10</label><element-citation publication-type="journal" id="sref10"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>C.Y.</given-names></name><name><surname>Chang</surname><given-names>Y.F.</given-names></name><name><surname>Lee</surname><given-names>C.L.</given-names></name><name><surname>Wu</surname><given-names>M.C.</given-names></name><name><surname>Ho</surname><given-names>C.L.</given-names></name><name><surname>Chang</surname><given-names>Y.C.</given-names></name></person-group><article-title>Molecular viral epidemiology and clinical characterization of acute febrile respiratory infections in hospitalized children in Taiwan</article-title><source>J Med Virol</source><volume>87</volume><issue>11</issue><year>2015</year><fpage>1860</fpage><lpage>1866</lpage><pub-id pub-id-type="pmid">26089293</pub-id></element-citation></ref><ref id="bib11"><label>11</label><element-citation publication-type="journal" id="sref11"><person-group person-group-type="author"><name><surname>Scotta</surname><given-names>M.C.</given-names></name><name><surname>Chakr</surname><given-names>V.C.</given-names></name><name><surname>de Moura</surname><given-names>A.</given-names></name><name><surname>Becker</surname><given-names>R.G.</given-names></name><name><surname>de Souza</surname><given-names>A.P.</given-names></name><name><surname>Jones</surname><given-names>M.H.</given-names></name></person-group><article-title>Respiratory viral coinfection and disease severity in children: a systematic review and meta-analysis</article-title><source>J Clin Virol</source><volume>80</volume><year>2016</year><fpage>45</fpage><lpage>56</lpage><pub-id pub-id-type="pmid">27155055</pub-id></element-citation></ref><ref id="bib12"><label>12</label><element-citation publication-type="journal" id="sref12"><person-group person-group-type="author"><name><surname>Chou</surname><given-names>C.A.</given-names></name><name><surname>Lin</surname><given-names>T.I.</given-names></name><name><surname>Chen</surname><given-names>Y.S.</given-names></name><name><surname>Liu</surname><given-names>P.Y.</given-names></name><name><surname>Huang</surname><given-names>Y.F.</given-names></name><name><surname>Chen</surname><given-names>Y.Y.</given-names></name></person-group><article-title>Comparisons of etiology and diagnostic tools of lower respiratory tract infections in hospitalized young children in Southern Taiwan in two seasons</article-title><source>J Microbiol Immunol Infect</source><volume>49</volume><issue>4</issue><year>2016</year><fpage>539</fpage><lpage>545</lpage><pub-id pub-id-type="pmid">25442857</pub-id></element-citation></ref><ref id="bib13"><label>13</label><element-citation publication-type="journal" id="sref13"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>E.T.</given-names></name><name><surname>Kuypers</surname><given-names>J.</given-names></name><name><surname>Wald</surname><given-names>A.</given-names></name><name><surname>Englund</surname><given-names>J.A.</given-names></name></person-group><article-title>Multiple versus single virus respiratory infections: viral load and clinical disease severity in hospitalized children</article-title><source>Influenza Other Respir Viruses</source><volume>6</volume><issue>1</issue><year>2012</year><fpage>71</fpage><lpage>77</lpage><pub-id pub-id-type="pmid">21668660</pub-id></element-citation></ref><ref id="bib14"><label>14</label><element-citation publication-type="journal" id="sref14"><person-group person-group-type="author"><name><surname>Gadsby</surname><given-names>N.J.</given-names></name><name><surname>Hardie</surname><given-names>A.</given-names></name><name><surname>Claas</surname><given-names>E.C.</given-names></name><name><surname>Templeton</surname><given-names>K.E.</given-names></name></person-group><article-title>Comparison of the Luminex Respiratory Virus Panel fast assay with in-house real-time PCR for respiratory viral infection diagnosis</article-title><source>J Clin Microbiol</source><volume>48</volume><issue>6</issue><year>2010</year><fpage>2213</fpage><lpage>2216</lpage><pub-id pub-id-type="pmid">20357215</pub-id></element-citation></ref><ref id="bib15"><label>15</label><element-citation publication-type="journal" id="sref15"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>K.H.</given-names></name><name><surname>To</surname><given-names>K.K.W.</given-names></name><name><surname>Li</surname><given-names>P.T.W.</given-names></name><name><surname>Wong</surname><given-names>T.L.</given-names></name><name><surname>Zhang</surname><given-names>R.</given-names></name><name><surname>Chik</surname><given-names>K.K.H.</given-names></name></person-group><article-title>Evaluation of NxTAG respiratory pathogen panel and comparison with xTAG respiratory viral panel fast v2 and film array respiratory panel for detecting respiratory pathogens in nasopharyngeal aspirates and swine/avian-origin influenza a subtypes in culture isolates</article-title><source>Adv Virol</source><volume>2017</volume><year>2017</year><fpage>1324276</fpage><pub-id pub-id-type="pmid">28947901</pub-id></element-citation></ref><ref id="bib16"><label>16</label><element-citation publication-type="journal" id="sref16"><person-group person-group-type="author"><name><surname>Asner</surname><given-names>S.A.</given-names></name><name><surname>Science</surname><given-names>M.E.</given-names></name><name><surname>Tran</surname><given-names>D.</given-names></name><name><surname>Smieja</surname><given-names>M.</given-names></name><name><surname>Merglen</surname><given-names>A.</given-names></name><name><surname>Mertz</surname><given-names>D.</given-names></name></person-group><article-title>Clinical disease severity of respiratory viral co-infection versus single viral infection: a systematic review and meta-analysis</article-title><source>PLoS One</source><volume>9</volume><issue>6</issue><year>2014</year><fpage>e99392</fpage><pub-id pub-id-type="pmid">24932493</pub-id></element-citation></ref><ref id="bib17"><label>17</label><element-citation publication-type="journal" id="sref17"><person-group person-group-type="author"><name><surname>Lim</surname><given-names>F.J.</given-names></name><name><surname>de Klerk</surname><given-names>N.</given-names></name><name><surname>Blyth</surname><given-names>C.C.</given-names></name><name><surname>Fathima</surname><given-names>P.</given-names></name><name><surname>Moore</surname><given-names>H.C.</given-names></name></person-group><article-title>Systematic review and meta-analysis of respiratory viral coinfections in children</article-title><source>Respirology</source><volume>21</volume><issue>4</issue><year>2016</year><fpage>648</fpage><lpage>655</lpage><pub-id pub-id-type="pmid">26919484</pub-id></element-citation></ref><ref id="bib18"><label>18</label><element-citation publication-type="journal" id="sref18"><person-group person-group-type="author"><name><surname>Goka</surname><given-names>E.A.</given-names></name><name><surname>Vallely</surname><given-names>P.J.</given-names></name><name><surname>Mutton</surname><given-names>K.J.</given-names></name><name><surname>Klapper</surname><given-names>P.E.</given-names></name></person-group><article-title>Single and multiple respiratory virus infections and severity of respiratory disease: a systematic review</article-title><source>Paediatr Respir Rev</source><volume>15</volume><issue>4</issue><year>2014</year><fpage>363</fpage><lpage>370</lpage><pub-id pub-id-type="pmid">24361079</pub-id></element-citation></ref><ref id="bib19"><label>19</label><element-citation publication-type="journal" id="sref19"><person-group person-group-type="author"><name><surname>Jartti</surname><given-names>T.</given-names></name><name><surname>Soderlund-Venermo</surname><given-names>M.</given-names></name><name><surname>Hedman</surname><given-names>K.</given-names></name><name><surname>Ruuskanen</surname><given-names>O.</given-names></name><name><surname>Makela</surname><given-names>M.J.</given-names></name></person-group><article-title>New molecular virus detection methods and their clinical value in lower respiratory tract infections in children</article-title><source>Paediatr Respir Rev</source><volume>14</volume><issue>1</issue><year>2013</year><fpage>38</fpage><lpage>45</lpage><pub-id pub-id-type="pmid">23347659</pub-id></element-citation></ref><ref id="bib20"><label>20</label><element-citation publication-type="journal" id="sref20"><person-group person-group-type="author"><name><surname>DaPalma</surname><given-names>T.</given-names></name><name><surname>Doonan</surname><given-names>B.P.</given-names></name><name><surname>Trager</surname><given-names>N.M.</given-names></name><name><surname>Kasman</surname><given-names>L.M.</given-names></name></person-group><article-title>A systematic approach to virus-virus interactions</article-title><source>Virus Res</source><volume>149</volume><issue>1</issue><year>2010</year><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">20093154</pub-id></element-citation></ref><ref id="bib21"><label>21</label><element-citation publication-type="journal" id="sref21"><person-group person-group-type="author"><name><surname>Semple</surname><given-names>M.G.</given-names></name><name><surname>Cowell</surname><given-names>A.</given-names></name><name><surname>Dove</surname><given-names>W.</given-names></name><name><surname>Greensill</surname><given-names>J.</given-names></name><name><surname>McNamara</surname><given-names>P.S.</given-names></name><name><surname>Halfhide</surname><given-names>C.</given-names></name></person-group><article-title>Dual infection of infants by human metapneumovirus and human respiratory syncytial virus is strongly associated with severe bronchiolitis</article-title><source>J Infect Dis</source><volume>191</volume><issue>3</issue><year>2005</year><fpage>382</fpage><lpage>386</lpage><pub-id pub-id-type="pmid">15633097</pub-id></element-citation></ref><ref id="bib22"><label>22</label><element-citation publication-type="journal" id="sref22"><person-group person-group-type="author"><name><surname>Hasegawa</surname><given-names>K.</given-names></name><name><surname>Jartti</surname><given-names>T.</given-names></name><name><surname>Mansbach</surname><given-names>J.M.</given-names></name><name><surname>Laham</surname><given-names>F.R.</given-names></name><name><surname>Jewell</surname><given-names>A.M.</given-names></name><name><surname>Espinola</surname><given-names>J.A.</given-names></name></person-group><article-title>Respiratory syncytial virus genomic load and disease severity among children hospitalized with bronchiolitis: multicenter cohort studies in the United States and Finland</article-title><source>J Infect Dis</source><volume>211</volume><issue>10</issue><year>2015</year><fpage>1550</fpage><lpage>1559</lpage><pub-id pub-id-type="pmid">25425699</pub-id></element-citation></ref><ref id="bib23"><label>23</label><element-citation publication-type="journal" id="sref23"><person-group person-group-type="author"><name><surname>Moesker</surname><given-names>F.M.</given-names></name><name><surname>van Kampen</surname><given-names>J.J.</given-names></name><name><surname>van Rossum</surname><given-names>A.M.</given-names></name><name><surname>de Hoog</surname><given-names>M.</given-names></name><name><surname>Koopmans</surname><given-names>M.P.</given-names></name><name><surname>Osterhaus</surname><given-names>A.D.</given-names></name></person-group><article-title>Viruses as sole causative agents of severe acute respiratory tract infections in children</article-title><source>PLoS One</source><volume>11</volume><issue>3</issue><year>2016</year><fpage>e0150776</fpage><pub-id pub-id-type="pmid">26964038</pub-id></element-citation></ref><ref id="bib24"><label>24</label><element-citation publication-type="journal" id="sref24"><person-group person-group-type="author"><name><surname>Heikkinen</surname><given-names>T.</given-names></name><name><surname>Jarvinen</surname><given-names>A.</given-names></name></person-group><article-title>The common cold</article-title><source>Lancet</source><volume>361</volume><issue>9351</issue><year>2003</year><fpage>51</fpage><lpage>59</lpage><pub-id pub-id-type="pmid">12517470</pub-id></element-citation></ref><ref id="bib25"><label>25</label><element-citation publication-type="journal" id="sref25"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>T.</given-names></name><name><surname>McLean</surname><given-names>K.</given-names></name><name><surname>Campbell</surname><given-names>H.</given-names></name><name><surname>Nair</surname><given-names>H.</given-names></name></person-group><article-title>Aetiological role of common respiratory viruses in acute lower respiratory infections in children under five years: a systematic review and meta-analysis</article-title><source>J Glob Health</source><volume>5</volume><issue>1</issue><year>2015</year><fpage>010408</fpage><pub-id pub-id-type="pmid">26445672</pub-id></element-citation></ref><ref id="bib26"><label>26</label><element-citation publication-type="journal" id="sref26"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>K.W.</given-names></name><name><surname>Wang</surname><given-names>S.M.</given-names></name><name><surname>Shen</surname><given-names>C.F.</given-names></name><name><surname>Ho</surname><given-names>T.S.</given-names></name><name><surname>Wang</surname><given-names>J.R.</given-names></name><name><surname>Liu</surname><given-names>C.C.</given-names></name></person-group><article-title>Clinical and epidemiological characteristics of human parainfluenza virus infections of children in southern Taiwan</article-title><source>J Microbiol Immunol Infect</source><volume>51</volume><issue>6</issue><year>2018</year><fpage>749</fpage><lpage>755</lpage><pub-id pub-id-type="pmid">28757139</pub-id></element-citation></ref><ref id="bib27"><label>27</label><element-citation publication-type="journal" id="sref27"><person-group person-group-type="author"><name><surname>Zeng</surname><given-names>Z.Q.</given-names></name><name><surname>Chen</surname><given-names>D.H.</given-names></name><name><surname>Tan</surname><given-names>W.P.</given-names></name><name><surname>Qiu</surname><given-names>S.Y.</given-names></name><name><surname>Xu</surname><given-names>D.</given-names></name><name><surname>Liang</surname><given-names>H.X.</given-names></name></person-group><article-title>Epidemiology and clinical characteristics of human coronaviruses OC43, 229E, NL63, and HKU1: a study of hospitalized children with acute respiratory tract infection in Guangzhou, China</article-title><source>Eur J Clin Microbiol Infect Dis &#x02013; Offic Public Eur Soc Clin Microbiol</source><volume>37</volume><issue>2</issue><year>2018</year><fpage>363</fpage><lpage>369</lpage></element-citation></ref><ref id="bib28"><label>28</label><element-citation publication-type="journal" id="sref28"><person-group person-group-type="author"><name><surname>Franz</surname><given-names>A.</given-names></name><name><surname>Adams</surname><given-names>O.</given-names></name><name><surname>Willems</surname><given-names>R.</given-names></name><name><surname>Bonzel</surname><given-names>L.</given-names></name><name><surname>Neuhausen</surname><given-names>N.</given-names></name><name><surname>Schweizer-Krantz</surname><given-names>S.</given-names></name></person-group><article-title>Correlation of viral load of respiratory pathogens and co-infections with disease severity in children hospitalized for lower respiratory tract infection</article-title><source>J Clin Virol</source><volume>48</volume><issue>4</issue><year>2010</year><fpage>239</fpage><lpage>245</lpage><pub-id pub-id-type="pmid">20646956</pub-id></element-citation></ref><ref id="bib29"><label>29</label><element-citation publication-type="journal" id="sref29"><person-group person-group-type="author"><name><surname>Tsagarakis</surname><given-names>N.J.</given-names></name><name><surname>Sideri</surname><given-names>A.</given-names></name><name><surname>Makridis</surname><given-names>P.</given-names></name><name><surname>Triantafyllou</surname><given-names>A.</given-names></name><name><surname>Stamoulakatou</surname><given-names>A.</given-names></name><name><surname>Papadogeorgaki</surname><given-names>E.</given-names></name></person-group><article-title>Age-related prevalence of common upper respiratory pathogens, based on the application of the FilmArray Respiratory panel in a tertiary hospital in Greece</article-title><source>Medicine</source><volume>97</volume><issue>22</issue><year>2018</year><fpage>e10903</fpage><pub-id pub-id-type="pmid">29851817</pub-id></element-citation></ref><ref id="bib30"><label>30</label><element-citation publication-type="journal" id="sref30"><person-group person-group-type="author"><name><surname>Weissbrich</surname><given-names>B.</given-names></name><name><surname>Neske</surname><given-names>F.</given-names></name><name><surname>Schubert</surname><given-names>J.</given-names></name><name><surname>Tollmann</surname><given-names>F.</given-names></name><name><surname>Blath</surname><given-names>K.</given-names></name><name><surname>Blessing</surname><given-names>K.</given-names></name></person-group><article-title>Frequent detection of bocavirus DNA in German children with respiratory tract infections</article-title><source>BMC Infect Dis</source><volume>6</volume><year>2006</year><fpage>109</fpage><pub-id pub-id-type="pmid">16834781</pub-id></element-citation></ref><ref id="bib31"><label>31</label><element-citation publication-type="journal" id="sref31"><person-group person-group-type="author"><name><surname>Allander</surname><given-names>T.</given-names></name><name><surname>Jartti</surname><given-names>T.</given-names></name><name><surname>Gupta</surname><given-names>S.</given-names></name><name><surname>Niesters</surname><given-names>H.G.</given-names></name><name><surname>Lehtinen</surname><given-names>P.</given-names></name><name><surname>Osterback</surname><given-names>R.</given-names></name></person-group><article-title>Human bocavirus and acute wheezing in children</article-title><source>Clin Infect Dis</source><volume>44</volume><issue>7</issue><year>2007</year><fpage>904</fpage><lpage>910</lpage><pub-id pub-id-type="pmid">17342639</pub-id></element-citation></ref><ref id="bib32"><label>32</label><element-citation publication-type="journal" id="sref32"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>H.J.</given-names></name><name><surname>Seo</surname><given-names>Y.E.</given-names></name><name><surname>Han</surname><given-names>S.B.</given-names></name><name><surname>Jeong</surname><given-names>D.C.</given-names></name><name><surname>Kang</surname><given-names>J.H.</given-names></name></person-group><article-title>Clinical impact of mixed respiratory viral infection in children with adenoviral infection</article-title><source>Infect Chemother</source><volume>48</volume><issue>4</issue><year>2016</year><fpage>309</fpage><lpage>316</lpage><pub-id pub-id-type="pmid">27883373</pub-id></element-citation></ref><ref id="bib33"><label>33</label><element-citation publication-type="journal" id="sref33"><person-group person-group-type="author"><name><surname>Goka</surname><given-names>E.A.</given-names></name><name><surname>Vallely</surname><given-names>P.J.</given-names></name><name><surname>Mutton</surname><given-names>K.J.</given-names></name><name><surname>Klapper</surname><given-names>P.E.</given-names></name></person-group><article-title>Single, dual and multiple respiratory virus infections and risk of hospitalization and mortality</article-title><source>Epidemiol Infect</source><volume>143</volume><issue>1</issue><year>2015</year><fpage>37</fpage><lpage>47</lpage><pub-id pub-id-type="pmid">24568719</pub-id></element-citation></ref><ref id="bib34"><label>34</label><element-citation publication-type="journal" id="sref34"><person-group person-group-type="author"><name><surname>Botti</surname><given-names>C.</given-names></name><name><surname>Micillo</surname><given-names>A.</given-names></name><name><surname>Ricci</surname><given-names>G.</given-names></name><name><surname>Russo</surname><given-names>A.</given-names></name><name><surname>Denisco</surname><given-names>A.</given-names></name><name><surname>Cantile</surname><given-names>M.</given-names></name></person-group><article-title>Characterization of respiratory infection viruses in hospitalized children from Naples province in Southern Italy</article-title><source>Exp Ther Med</source><volume>15</volume><issue>6</issue><year>2018</year><fpage>4805</fpage><lpage>4809</lpage><pub-id pub-id-type="pmid">29805499</pub-id></element-citation></ref><ref id="bib35"><label>35</label><element-citation publication-type="journal" id="sref35"><person-group person-group-type="author"><name><surname>Richter</surname><given-names>J.</given-names></name><name><surname>Panayiotou</surname><given-names>C.</given-names></name><name><surname>Tryfonos</surname><given-names>C.</given-names></name><name><surname>Koptides</surname><given-names>D.</given-names></name><name><surname>Koliou</surname><given-names>M.</given-names></name><name><surname>Kalogirou</surname><given-names>N.</given-names></name></person-group><article-title>Aetiology of acute respiratory tract infections in hospitalised children in Cyprus</article-title><source>PLoS One</source><volume>11</volume><issue>1</issue><year>2016</year><fpage>e0147041</fpage><pub-id pub-id-type="pmid">26761647</pub-id></element-citation></ref><ref id="bib36"><label>36</label><element-citation publication-type="journal" id="sref36"><person-group person-group-type="author"><name><surname>Regamey</surname><given-names>N.</given-names></name><name><surname>Frey</surname><given-names>U.</given-names></name><name><surname>Deffernez</surname><given-names>C.</given-names></name><name><surname>Latzin</surname><given-names>P.</given-names></name><name><surname>Kaiser</surname><given-names>L.</given-names></name><collab>Swiss Paediatric Respiratory Research G</collab></person-group><article-title>Isolation of human bocavirus from Swiss infants with respiratory infections</article-title><source>Pediatr Infect Dis J</source><volume>26</volume><issue>2</issue><year>2007</year><fpage>177</fpage><lpage>179</lpage><pub-id pub-id-type="pmid">17259883</pub-id></element-citation></ref><ref id="bib37"><label>37</label><element-citation publication-type="journal" id="sref37"><person-group person-group-type="author"><name><surname>Bicer</surname><given-names>S.</given-names></name><name><surname>Kucuk</surname><given-names>O.</given-names></name><name><surname>Giray</surname><given-names>T.</given-names></name><name><surname>Col</surname><given-names>D.</given-names></name><name><surname>Ciler Erdag</surname><given-names>G.</given-names></name><name><surname>Gurol</surname><given-names>Y.</given-names></name></person-group><article-title>Evaluation of clinical and laboratory findings of pediatric patients with adenovirus-associated respiratory tract infections</article-title><source>Mikrobiyol Bul</source><volume>47</volume><issue>2</issue><year>2013</year><fpage>295</fpage><lpage>304</lpage><pub-id pub-id-type="pmid">23621729</pub-id></element-citation></ref><ref id="bib38"><label>38</label><element-citation publication-type="journal" id="sref38"><person-group person-group-type="author"><name><surname>Heimdal</surname><given-names>I.</given-names></name><name><surname>Moe</surname><given-names>N.</given-names></name><name><surname>Krokstad</surname><given-names>S.</given-names></name><name><surname>Christensen</surname><given-names>A.</given-names></name><name><surname>Skanke</surname><given-names>L.H.</given-names></name><name><surname>Nordbo</surname><given-names>S.A.</given-names></name></person-group><article-title>Human coronavirus in hospitalized children with respiratory tract infections: a 9-year population-based study from Norway</article-title><source>J Infect Dis</source><volume>219</volume><issue>8</issue><year>2019</year><fpage>1198</fpage><lpage>1206</lpage><pub-id pub-id-type="pmid">30418633</pub-id></element-citation></ref><ref id="bib39"><label>39</label><element-citation publication-type="journal" id="sref39"><person-group person-group-type="author"><name><surname>Sung</surname><given-names>C.C.</given-names></name><name><surname>Chi</surname><given-names>H.</given-names></name><name><surname>Chiu</surname><given-names>N.C.</given-names></name><name><surname>Huang</surname><given-names>D.T.</given-names></name><name><surname>Weng</surname><given-names>L.C.</given-names></name><name><surname>Wang</surname><given-names>N.Y.</given-names></name></person-group><article-title>Viral etiology of acute lower respiratory tract infections in hospitalized young children in Northern Taiwan</article-title><source>J Microbiol Immunol Infect</source><volume>44</volume><issue>3</issue><year>2011</year><fpage>184</fpage><lpage>190</lpage><pub-id pub-id-type="pmid">21524612</pub-id></element-citation></ref></ref-list><sec id="appsec1" sec-type="supplementary-material"><label>Appendix A</label><title>Supplementary data</title><p id="p0235">The following are the Supplementary data to this article:<supplementary-material content-type="local-data" id="mmc1"><caption><title>Multimedia component 1</title></caption><media xlink:href="mmc1.docx"><alt-text>Multimedia component 1</alt-text></media></supplementary-material>
<supplementary-material content-type="local-data" id="mmc2"><caption><title>Multimedia component 2</title></caption><media xlink:href="mmc2.docx"><alt-text>Multimedia component 2</alt-text></media></supplementary-material>
</p></sec><fn-group><fn id="appsec2" fn-type="supplementary-material"><label>Appendix A</label><p id="p0240">Supplementary data to this article can be found online at <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.jmii.2019.08.013" id="intref0010">https://doi.org/10.1016/j.jmii.2019.08.013</ext-link>.</p></fn></fn-group></back></article>